Actively Recruiting
Evaluating Tegileridine Versus Morphine for Pain Relief After Adolescent Scoliosis Surgery Using Patient-Controlled Analgesia
Led by Peking Union Medical College Hospital · Updated on 2026-10-13
171
Participants Needed
6
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the pain relief and safety of a new medicine called Tegileridine compared to the standard pain treatment morphine in teenagers undergoing spinal fusion surgery for scoliosis. This study is a non-inferiority trial designed to see if Tegileridine is at least as effective as morphine in controlling pain during the first 24 hours after surgery. It also aims to compare side effects like sleepiness and nausea between the two medicines. Participants will be randomly assigned to one of three groups two groups receive different doses of Tegileridine, and the third group receives morphine. All medications are given through a patient-controlled analgesia PCA pump after surgery, allowing participants to manage their own pain relief. The PCA pump is used for up to 48 hours, with doses delivered intravenously and prepared to look the same to keep the treatment blinded. During the study, participants will regularly rate their pain using a simple scale, and their health will be closely monitored for side effects such as low oxygen levels and sedation. Researchers will measure pain scores, use of additional pain medicine, patient satisfaction, and the occurrence of side effects over the 48-hour period. The overall hospital stay length will also be tracked, with safety and effectiveness data collected throughout the treatment period.
CONDITIONS
Brief Title
Tegileridine for Postoperative Pain After Adolescent Scoliosis Surgery
Research Team
J
Juelun Wu, Doctor
L
Ling Lan, Doctor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here